Keywords: Brazil, PharmaPraxis, Axis Biotec, Monoclonal antibodies, Manufacturing, Subsidiary

Brazil: PharmaPraxis in deal with Health Ministry to make MAbs; Eisai sets up subsidiary

Article | 08 April 2011

Print This

PharmaPraxis, part of Brazilian drugmaker Axis Biotec, has announced the formalization of an agreement with Brazil's Ministry of Health to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in